|
|
|
|
¡ù
Products ¡ù |
Index No. |
Products Name |
CAS |
Quality Standard
|
GMP / DMF
|
O-009 |
Tetramethrin |
7696-12-0 |
99.0% min. |
|
O-010 |
Permethrin |
52645-53-1 |
99.0% min. |
|
|
Dasatinib |
302962-49-8 |
|
|
|
Nilotinib |
641571-10-0 |
|
|
|
Nilotinib hydrochloride monohydrate |
923288-90-8 |
|
|
|
Ponatinib |
943319-70-8 |
|
|
|
Sorafenib |
284461-73-0 |
|
|
|
Sorafenib tosylate |
475207-59-1 |
|
|
|
Pomalidomide |
19171-19-8 |
|
|
|
Lapatinib |
231277-92-2 |
|
|
|
Lapatinib ditosylate |
388082-78-8 |
|
|
|
Nitisinone |
104206-65-7 |
|
|
|
Tofacitinib citrate |
540737-29-9 |
|
|
|
Pazopanib |
444731-52-6 |
|
|
|
Pazopanib hydrochloride |
635702-64-6 |
|
|
|
Osimertinib azd9291 |
1421373-65-0 |
|
|
|
AZD-9291 |
1421373-65-0 |
|
|
|
Osimertinib |
1421373-66-1 |
|
|
|
Trametinib |
871700-17-3 |
|
|
|
3-cycloproppyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione |
871700-24-2 |
|
|
|
3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl 4-methylbenzenesulfonate |
871700-32-2 |
|
|
|
Bosentan |
147536-97-8 |
|
|
|
Lenalidomide |
191732-72-6 |
|
|
|
3-Methyl-6-nitro-1H-indazole |
6494-19-5 |
|
|
|
3-Methyl-6-nitroindazole |
6494-19-5 |
|
|
|
2,3-dimethyl-6-nitroindazole |
444731-73-1 |
|
|
|
2,3-Dimethyl-6-Nitro-2H-Indazole |
|
|
|
|
2,3-dimethyl-2H-indazol-6-amine |
444731-72-0 |
|
|
|
2,3-dimethylindazol-6-amine |
|
|
|
|
N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine |
444731-74-2 |
|
|
|
|
|
|
|
|